Literature DB >> 19201553

Detection of bovine leukemia virus specific antibodies using recombinant p24-ELISA.

G Gutiérrez1, I Alvarez, N Fondevila, R Politzki, M Lomónaco, S Rodríguez, M J Dus Santos, K Trono.   

Abstract

We developed an indirect ELISA test (rp24-ELISA) for the detection of antibodies against the p24 capsid protein of bovine leukemia virus (BLV) in bovine serum samples. A recombinant p24 (rp24) was expressed in the Escherichia coli expression system, purified in a nickel charged resin and used as antigen in the ELISA test. A cut-off point was established considering the distribution of reactivity values obtained by rp24-ELISA on a set of 555 field serum samples that were stated as double positive (DP) or double negative (DN) by the combination of commercial agar gel immunodiffusion (AGID) assay and gp51-ELISA tests results. The rp24-ELISA showed good concordance with the agar gel immunodiffusion assay, when 710 serum samples were analyzed. In addition, rp24-ELISA demonstrated to be a precise assay with good repeatability and reproducibility and a better analytical sensitivity than AGID. From 67 discordant rp24-ELISA-AGID sera, 4 negative reactors were from the DP group, 28 positive samples were from the DN group and 35 positive samples were stated as negative by AGID but positive by the gp51-ELISA. Samples from this last subgroup were sent to an OIE reference laboratory where 28 samples were stated as negative, 5 samples were stated as positive and 2 as inconclusive. Complete concordance with blind previous results from an international proficiency test panel confirmed the capability of the assay to discriminate between infected and non-infected animals. In conclusion, the rp24-ELISA developed and standardized demonstrated to have good analytical characteristics to be considered for screening of BLV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19201553     DOI: 10.1016/j.vetmic.2009.01.022

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  6 in total

1.  Expression of p24 gag protein of bovine leukemia virus in insect cells and its use in immunodetection of the disease.

Authors:  Alejandra Larsen; Ester Teresa Gonzalez; María Soledad Serena; María Gabriela Echeverría; Eduardo Mortola
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

2.  Genome-wide scan for commons SNPs affecting bovine leukemia virus infection level in dairy cattle.

Authors:  Hugo A Carignano; Dana L Roldan; María J Beribe; María A Raschia; Ariel Amadio; Juan P Nani; Gerónimo Gutierrez; Irene Alvarez; Karina Trono; Mario A Poli; Marcos M Miretti
Journal:  BMC Genomics       Date:  2018-02-13       Impact factor: 3.969

Review 3.  Bovine Leukaemia Virus: Current Epidemiological Circumstance and Future Prospective.

Authors:  Marawan A Marawan; Abdulaziz Alouffi; Suleiman El Tokhy; Sara Badawy; Ihsanullah Shirani; Ali Dawood; Aizhen Guo; Mashal M Almutairi; Fahdah Ayed Alshammari; Abdelfattah Selim
Journal:  Viruses       Date:  2021-10-27       Impact factor: 5.048

4.  A safe and effective vaccine against bovine leukemia virus.

Authors:  Guillermo Suárez Archilla; Gerónimo Gutiérrez; Cecilia Camussone; Luis Calvinho; Alejandro Abdala; Irene Alvarez; Marcos Petersen; Lautaro Franco; Gabriel Destefano; Gustavo Monti; Jean-Rock Jacques; Thomas Joris; Luc Willems; Karina Trono
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

5.  Bovine leukemia virus p24 antibodies reflect blood proviral load.

Authors:  Gerónimo Gutiérrez; Hugo Carignano; Irene Alvarez; Cecilia Martínez; Natalia Porta; Romina Politzki; Mariela Gammella; Marina Lomonaco; Norberto Fondevila; Mario Poli; Karina Trono
Journal:  BMC Vet Res       Date:  2012-10-09       Impact factor: 2.741

6.  Development of an indirect ELISA based on recombinant capsid protein to detect antibodies to bovine leukemia virus.

Authors:  Ana Paula Andreolla; Luana Marina Scheer Erpen; Rafael Frandoloso; Luiz Carlos Kreutz
Journal:  Braz J Microbiol       Date:  2018-05-22       Impact factor: 2.476

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.